期刊文献+

氯吡格雷联合阿司匹林治疗短暂性脑缺血发作的临床探析 被引量:3

原文传递
导出
摘要 短暂性脑缺血发作是脑梗死的预警信号,如果不能对该疾病进行良好的治疗,就有很大可能导致脑梗死的现象出现,甚至有一部分患者会在7d之内出现脑梗死的情况,
作者 江利敏
出处 《中华脑科疾病与康复杂志(电子版)》 2014年第4期61-62,共2页 Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition)
  • 相关文献

参考文献10

  • 1扬艳敏,潘作东,郑佳慧,等.老年短暂性脑缺血发作与C反应蛋白和D-二聚体关系探讨[J].中国实用内科杂志,2013,26(17):128-129.
  • 2俞龙,徐耀,王子欣,等.短暂性脑缺血发作与血栓前体蛋白及纤维蛋白原的关系[J].临床神经病学杂志,2012,18(12):114-115.
  • 3许二赫,马中华,贾建平.脑梗死患者阿司匹林抵抗的临床特征分析[J].中国老年学杂志,2008,28(23):2333-2335. 被引量:7
  • 4王东闰,丰宏林,张铁林.脑梗死患者阿司匹林抵抗的临床研究[J].齐齐哈尔医学院学报,2011,21(11):107-108.
  • 5王为强,任明山,杨毅.用ABCD^2评分法预测短暂性脑缺血发作短期进展为脑梗死的风险[J].中国临床保健杂志,2009,12(3):248-250. 被引量:8
  • 6Cavallari LH,Helgason CM,Brace LD, et al. Sex difference in the antiplatelet effect of aspirin in patients with stroke [ J ]. Ann Pharmacother,2012,12 (6) :384-387.
  • 7Weir NU, Demchuk AM, Buehan AM, et al. Stroke prevention. MATCHing therapy to the patient with TIA [ J ]. Postgraduate Medicine ,2012,17 ( 11 ) : 123-125.
  • 8Wong KS. Is the measurement of cerebral micro-embolic signals agood surrogate marker for evaluating the efficacy of antiplateletagents in the prevention of stroke [ J ]. European Neurology ,2012,21 ( 13 ) : 101-107.
  • 9李正侠,郭晋,孙廷强.氯吡格雷联合阿司匹林治疗短暂性脑缺血发作73例临床疗效观察[J].中华临床医师杂志(电子版),2012,6(18):201-202. 被引量:24
  • 10Rothwell PM, Warlow CP. Timing of TIAs preceding stroke: time window for prevention is very short [ J ]. Neurology, 2012,21 ( 17 ) : 101-107.

二级参考文献25

  • 1王坚苗,张苏明.短暂性脑缺血发作的新认识[J].国外医学(脑血管疾病分册),2005,13(2):110-115. 被引量:22
  • 2李宏建.阿司匹林与氯吡格雷联用对缺血性卒中的二级预防无明显益处[J].国际脑血管病杂志,2006,14(5):364-364. 被引量:3
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33066
  • 4Antiplatelet Trialist' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy- Ⅰ - Ⅲ[ J ]. BMJ, 1994 ;308 (6921-6923 ) : 81- 106,159-68,235-46.
  • 5Antiplatelet Trialist's Collaboration. Collaborative overview of randomized trial of antiplatelet therapy, Ⅰ: prevention of death, myocardial infarction, and stroke by prolonged antiplatet therapy in various categoties of patients BMJ, 1994 ;308 (6921) :81-106
  • 6Helgason CM, Bolin KM, Hoff JA, et al. Development of aspirin resistance in persons with previous ischemic stroke [ J ]. Stroke, 1994 ;25:2331-6.
  • 7Pappas JM, Westengard JC, Bull BS. Population variability in the effect of aspirin on platelet function: implication for clinical trials and therapy [J]. Arch Pathol Lab Med,1994;118:801-4.
  • 8Grotemeyer KH, Scharafinski HW, Husstedt IW. Two-year follow-up of aspirin responder and aspirin non-responder: a pilot-study including 180 post-stroke patients [J]. Thromb Res, 1993 ;71 : 397-403.
  • 9Gum PA, Kotike-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease[ J]. Am J Cardiol,2001 ;88:230-5.
  • 10Weber AA, Przytulski B, Schanz A, et al. Towards a definition of aspirin resistance : a typological approach [ J ]. Platelets, 2002 ; 13 ( 1 ) : 37 -40.

共引文献35

同被引文献30

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部